Two Sigma Investments, LP Denali Therapeutics Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 99,467 shares of DNLI stock, worth $2.14 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

99,467

Previous 94,867 4.85%

Holding current value

$2.14 Million

Previous $2.2 Million 31.56%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$20.96 - $31.05 $96,416 - $142,830	4,600 Added 4.85%	99,467 $2.9 Million
Q2 2024 Aug 14, 2024	SELL	$14.96 - $23.22 $1.45 Million - $2.24 Million	-96,638 Reduced 50.46%	94,867 $2.2 Million
Q1 2024 May 15, 2024	BUY	$15.83 - $23.35 $2.58 Million - $3.81 Million	163,129 Added 574.88%	191,505 $3.93 Million
Q4 2023 Feb 14, 2024	BUY	$16.2 - $23.18 $459,691 - $657,755	28,376 New	28,376 $608,000
Q2 2023 Aug 14, 2023	SELL	$23.37 - $32.96 $966,139 - $1.36 Million	-41,341 Reduced 54.58%	34,400 $1.02 Million
Q1 2023 May 15, 2023	BUY	$21.91 - $32.67 $28,614 - $42,667	1,306 Added 1.75%	75,741 $1.75 Million
Q4 2022 Feb 14, 2023	SELL	$26.28 - $33.92 $4.91 Million - $6.33 Million	-186,735 Reduced 71.5%	74,435 $2.07 Million
Q3 2022 Nov 14, 2022	BUY	$25.97 - $38.53 $5.11 Million - $7.58 Million	196,846 Added 306.02%	261,170 $8.02 Million
Q2 2022 Aug 15, 2022	BUY	$20.88 - $35.19 $716,664 - $1.21 Million	34,323 Added 114.41%	64,324 $1.89 Million
Q1 2022 May 16, 2022	BUY	$29.0 - $47.27 $621,325 - $1.01 Million	21,425 Added 249.83%	30,001 $965,000
Q4 2021 Feb 14, 2022	SELL	$42.59 - $55.02 $4.48 Million - $5.78 Million	-105,095 Reduced 92.46%	8,576 $382,000
Q3 2021 Nov 15, 2021	SELL	$48.48 - $78.23 $5.13 Million - $8.27 Million	-105,744 Reduced 48.19%	113,671 $5.74 Million
Q2 2021 Aug 16, 2021	SELL	$50.3 - $78.44 $13.9 Million - $21.8 Million	-277,288 Reduced 55.83%	219,415 $17.2 Million
Q1 2021 May 17, 2021	BUY	$53.8 - $81.53 $12.7 Million - $19.2 Million	235,633 Added 90.26%	496,703 $28.4 Million
Q4 2020 Feb 16, 2021	BUY	$36.89 - $93.56 $2.58 Million - $6.55 Million	70,025 Added 36.65%	261,070 $21.9 Million
Q3 2020 Nov 16, 2020	BUY	$23.13 - $38.84 $1.52 Million - $2.54 Million	65,507 Added 52.18%	191,045 $6.85 Million
Q2 2020 Aug 14, 2020	BUY	$16.01 - $28.82 $2.01 Million - $3.62 Million	125,538 New	125,538 $3.04 Million

Others Institutions Holding DNLI

# of Institutions

227

Shares Held

119M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Denali Therapeutics Inc. Transaction History